CIDECP1: A Potential Drug Target and Biomarker (G152302)

Target Name: CIDECP1

NCBI ID: G152302

CIDECP1

Other Name(s): CIDEC pseudogene 1 | CICE | CIDECP

CIDECP1: A Potential Drug Target and Biomarker

Introduction

CIDECP1, or CIDEC pseudogene 1, is a gene that encodes a protein located in the endoplasmic reticulum (ER) of eukaryotic cells. The ER is a membrane-wrapped structure that contains many different types of membrane proteins, including transporters, enzymes, and Transfer RNA, etc. CIDECP1 protein plays important biological functions in cells, such as participating in cell signaling, metabolic regulation, immune response and intracellular transport.

In recent years, scientists have studied more and more CIDECP1 and gained a deeper understanding of its functions. Currently, CIDECP1 is considered a potential drug target and may also be an important biomarker. This article will introduce in detail the structure, function, drug target properties and application prospects of CIDECP1 as a biomarker.

structure

The CIDECP1 gene is located on the 11th pair of human chromosomes (11p11.2). The protein encoded by this gene consists of 254 amino acids and has a molecular weight of 30.1 kDa. CIDECP1 is located on the endoplasmic reticulum membrane in cells and is responsible for the modification and transport of membrane proteins.

Function

CIDECP1 plays a variety of important biological functions in cells. First, CIDECP1 is part of the intracellular transport system. It helps transport proteins and other macromolecules within cells by binding to transfer RNA. Secondly, CIDECP1 is involved in cell signaling. In cells, CIDECP1 binds to signal transduction molecules such as insulin receptors, thyroid hormone receptors, and growth factor receptors, thereby participating in intracellular signal transduction. In addition, CIDECP1 is also involved in the regulation of intracellular metabolism.

Drug target properties

As a drug target, CIDECP1 has various properties. First, CIDECP1 is a transmembrane protein with a significant half-life on the cell membrane. Secondly, CIDECP1 has multiple functions within cells, such as participating in cell signaling, metabolic regulation, and intracellular transport, so it is an attractive drug target. In addition, the expression level of CIDECP1 is regulated by a variety of physiological and pathological conditions, such as age, gender, tumor type, and drug exposure, which also makes it a potential drug target.

Application prospects as biomarkers

As a protein, CIDECP1 has broad application prospects in biomedical research. First, CIDECP1 can be used as a target for drug development. Through drug intervention targeting CIDECP1, various biological processes in cells can be regulated, such as cell signaling, metabolic regulation, and intracellular transport. Secondly, CIDECP1 can be used as a biomarker for diseases such as tumors. Since CIDECP1 is up-regulated in various tumor types, it can be used as a target for diagnosis, monitoring and treatment of tumors and other diseases.

in conclusion

CIDECP1 is a transmembrane protein that plays a variety of important biological functions in cells. In recent years, scientists have studied more and more CIDECP1 and gained a deeper understanding of its functions. As a drug target, CIDECP1 has multiple properties, including transmembrane properties, long half-life, and multiple functions. At the same time, CIDECP1 can also be used as a biomarker for drug development and diagnosis, monitoring and treatment of tumors and other diseases. With the deepening of research, CIDECP1 will become a molecule with broad application prospects.

Protein Name: CIDEC Pseudogene 1

The "CIDECP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CIDECP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets